GlobalData on MSN2d
FDA authorises ImmunityBio’s BCG alternative to treat bladder cancerImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...
The list of what is on top of our mind is much broader than in the past,” says Christophe Weber, Takeda’s president and CEO, ...
IFLScience on MSN2d
New mRNA Vaccine Against World's Biggest Infectious Killer Shows PromiseA new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...
The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...
ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA ...
Developed by the Serum Institute of India, the rBCG product, which has been modified to improve its immunogenicity and safety, was evaluated in phase 1/2 clinical trials in Europe in patients with ...
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials ...
In a tight economy, disciplined cost management is often a better path than absorbing margin pressures or passing costs to ...
ImmunityBio (IBRX) announced the U.S. Food and Drug Administration FDA has authorized an expanded access program EAP that will bring a vital ...
Coding assistance and completion tools saved developers around 4 million hours last year, the retailer said during an ...
A beverage company thinks like a startup to maintain a closer connection with its customers. That’s the word from a recent episode of MIT’s and BCG’s Me, Myself, and AI, which featured Ronald den ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback